Potential antiviral role of p53 in HCV-infected patients

被引：0
|
作者：
Hamdi, N. [1 ]
El-Serafy, M. [2 ]
Esmat, G. [2 ]
Alaakel, W. [2 ]
Abdelaziz, A. I. [1 ]
机构：
[1] German Univ Cairo, Cairo, Egypt
[2] Cairo Univ, Cairo, Egypt
来源：
FEBS JOURNAL | 2009年 / 276卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：312 / 313
页数：2
相关论文
共 50 条
  • [31] SAFETY AND ANTIVIRAL ACTIVITY OF TMC435350 IN TREATMENT-NAME GENOTYPE 1 HCV-INFECTED PATIENTS
    Manns, Michael P.
    Reesink, Hendrik W.
    Moreno, Christophe
    Berg, Thomas
    Benhamou, Yves
    Horsmans, Yves J.
    Dusheiko, Geoffrey M.
    Flisiak, Robert
    Meyvisch, Paul
    Lenz, Oliver
    Simmen, Kenneth
    Verloes, Rene
    HEPATOLOGY, 2008, 48 (04) : 1023A - 1023A
  • [32] Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agents
    Schiavinato, A.
    Zanetto, A.
    Pantano, G.
    Tosato, F.
    Nabergoj, M.
    Fogar, P.
    Piva, E.
    Gambato, M.
    Franceschet, E.
    Floreani, A.
    Farinati, F.
    Burra, P.
    Russo, F. P.
    Plebani, M.
    JOURNAL OF VIRAL HEPATITIS, 2017, 24 (12) : 1168 - 1176
  • [33] Long-term follow-up of HCV-infected hematopoietic SCT patients and effects of antiviral therapy
    P Ljungman
    A Locasciulli
    V G de Soria
    A N Békássy
    L Brinch
    I Espigado
    A Ferrant
    I M Franklin
    J O'Riordan
    M Rovira
    P Shaw
    H Einsele
    Bone Marrow Transplantation, 2012, 47 : 1217 - 1221
  • [34] Intravenous silibinin monotherapy shows significant antiviral activity in HCV-infected patients in the peri-transplantation period
    Marino, Zoe
    Crespo, Gonzalo
    D'Amato, Massimo
    Brambilla, Nadia
    Giacovelli, Giampaolo
    Rovati, Lucio
    Costa, Josep
    Navasa, Miguel
    Forns, Xavier
    JOURNAL OF HEPATOLOGY, 2013, 58 (03) : 415 - 420
  • [35] Long-term follow-up of HCV-infected hematopoietic SCT patients and effects of antiviral therapy
    Ljungman, P.
    Locasciulli, A.
    de Soria, V. G.
    Bekassy, A. N.
    Brinch, L.
    Espigado, I.
    Ferrant, A.
    Franklin, I. M.
    O'Riordan, J.
    Rovira, M.
    Shaw, P.
    Einsele, H.
    BONE MARROW TRANSPLANTATION, 2012, 47 (09) : 1217 - 1221
  • [36] Expression and role of p53 in OLP patients
    Hadzi-Mihailovic, M.
    Stanimirovic, D.
    Petrovic, R.
    ORAL DISEASES, 2014, 20 : 14 - 14
  • [37] Cost Effectiveness of Transplanting HCV-Infected Livers Into Uninfected Recipients With Preemptive Antiviral Therapy
    Bethea, Emily D.
    Samur, Sumeyye
    Kanwal, Fasiha
    Ayer, Turgay
    Hur, Chin
    Roberts, Mark S.
    Terrault, Norah
    Chung, Raymond T.
    Chhatwal, Jagpreet
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (04) : 739 - +
  • [38] Differential effects of HCV therapy with direct-acting antiviral agents on lipids in the German multicenter cohort on direct antiviral agents in HCV-and HIV/HCV-infected patients (GECCO)
    Mauss, S.
    Berger, F.
    Ingiliz, P.
    Hueppe, D.
    Lutz, T.
    Simon, K. G.
    Schewe, K.
    Wasmuth, J. C.
    Busch, H.
    Baumgarten, A.
    Christensen, S.
    ANTIVIRAL THERAPY, 2015, 20 : A4 - A5
  • [39] High frequency of unrecognized mental disorders in HCV-infected patients
    Batista-Neves, Susana Carolina
    Quarantini, Lucas C.
    de Almeida, Amanda Galvao
    Bressan, Rodrigo A.
    Lacerda, Acioly Luiz
    de-Oliveira, Irismar R.
    Parana, Raymundo
    Miranda-Scippa, Angela
    GENERAL HOSPITAL PSYCHIATRY, 2008, 30 (01) : 80 - 82
  • [40] CLINICAL AND PATHOLOGICAL SPECTRUM OF PERIPHERAL NEUROPATHY IN HCV-INFECTED PATIENTS
    Tocco, P.
    Ferrari, S.
    Mariotto, S.
    Cavallaro, T.
    Bonetti, B.
    Monaco, S.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2013, 18 : 31 - 32
12345